– 26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population – – Robust responses observed...
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in...
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in...
Mika's cancer app is a certified medical device clinically proven to help cancer patients cope with both the physical and...
Twenty promising early-career clinical investigators join a year-long mentorship and training program led by renowned international leaders, aimed at shaping...
CARY, N.C., June 11, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
SARASOTA, Fla. and HUNTSVILLE, Ala., June 11, 2025 /PRNewswire/ -- World Precision Instruments (WPI), a global leader in transepithelial electrical resistance...
CHICAGO, June 11, 2025 /PRNewswire/ -- The Global Digital Health Market size is projected to be valued at USD 347.35 billion...
Swiss biotech excellence returns to BIO 2025 in Boston, where Switzerland Global Enterprise presents 45 cutting-edge Swiss companies at the...
SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Mezzion Pharma Co., Ltd. (Mezzion) announced a major milestone in their clinical...
Axtria Ignite 2025 Champions Life Sciences Innovation with a Focus on AI-driven transformations, Patient-Centricity, and Next-Generation TherapiesHonoring Excellence: Ignite Leadership...
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed...
PARIS, June 11, 2025 /PRNewswire/ -- NVIDIA GTC Paris at VivaTech -- DCAI today announced that Novo Nordisk has become a customer...
Following successful validation, the AI-driven bioactive discovery company announces $3.6 mm round to scale next-gen food-as-medicine metabolic health solutions TEL...
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR);...
SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage...
BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in...
LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...